Mucormycosis in diabetes mellitus

Authors

  • Prashant Khatiwada Kathmandu University School of Medical Sciences, Dhulikhel
  • Aditi Giri Kathmandu University School of Medical Sciences, Dhulikhel
  • Prasana Khatiwoda Richa Bajimaya Memorial Foundation, Kathmandu

DOI:

https://doi.org/10.3126/jaim.v1i2.6531

Keywords:

fungal infection, immunodeficiency, mucormycosis

Abstract

Mucormycosis is an opportunistic fulminant fungal infection, which mainly infects immunocompromised patients. Infection with mucormycosis can cause devastating rhino-orbital-cerebral and pulmonary infection with an extremely poor prognosis. The infection begins in the nose and paranasal sinuses due to inhalation of fungal spores. We report a case of mucormycosis in an uncontrolled diabetic patient to emphasize early diagnosis of this potentially fatal fungal infection. Rhino-orbitalcerebral mucormycosis is the most common manifestation in patients with diabetes mellitus. We also review the current concepts in management of mucormycosis. Mucormycosis remains difficult to treat and requires a multifaceted approach involving elimination of predisposing factors, surgical debridement, and anti-fungal therapy. Lipid formulations of Amphotericin B are the treatments of choice.

DOI: http://dx.doi.org/10.3126/jaim.v1i2.6531

Journal of Advances in Internal Medicine 2012;01(02):73-75

Downloads

Download data is not yet available.
Abstract
1602
PDF
644

Downloads

Published

2012-07-23

How to Cite

Khatiwada, P., Giri, A., & Khatiwoda, P. (2012). Mucormycosis in diabetes mellitus. Journal of Advances in Internal Medicine, 1(2), 73–75. https://doi.org/10.3126/jaim.v1i2.6531

Issue

Vol. 1 No. 2 (2012)

Section

Case Reports

License

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator.